Correlation between computed tomography findings and liver function parameters in chronic liver disease
DOI:
https://doi.org/10.53685/jshmdc.v6i1.308Keywords:
Chronic Liver Disease, Cirrhosis, Liver Function Tests, Tomography X-Ray Computed.Abstract
Background: Chronic liver disease (CLD) leads to cirrhosis, hepatocellular carcinoma (HCC), and liver failure. Non-invasive assessment tools are crucial for the early detection and management of these complications of CLD.
Objective: To determine the correlation between computed tomography findings and liver function parameters in patients with chronic liver disease.
Methods: This retrospective study was conducted in the Department of Radiology, Lady Reading Hospital, Peshawar, Pakistan from December 2024 to January 2025 after obtaining the Institutional ethical approval (Ref. No. 569 MTI/LRH). Medical records of 276 patients with CLD from 1st October 2023 to 30th September 2024 were reviewed. Data were retrieved from the radiology department and laboratory information systems. Data of adult patients were included if they had undergone a contrast-enhanced computed tomography (CT) and liver function tests (LFTs) and hematological tests done within seven days of the CT scan. CT reports were assessed for cirrhosis, ascites, splenomegaly, portal vein thrombosis (PVT), and hepatocellular carcinoma. LFTs and hematological tests included ALT, AST, bilirubin, albumin, INR, and platelet count. Statistical analysis involved Pearson’s correlation and multivariate logistic regression.
Results: Cirrhosis was present in 96.7%, ascites in 64.1%, splenomegaly in 47.8%, PVT in 40.2%, and HCC in 73.9%. There was a significant negative correlation (r= –0.81, p<0.001) between cirrhosis and serum albumin levels. The severity of ascites correlated positively (r=0.70, p=0.008) with serum bilirubin levels and INR (r=0.60, p=0.010), indicating worsening of hepatic function. Splenomegaly was significantly correlated with reduced platelet counts (r = –0.75, p< 0.001).
Conclusion: CT findings in chronic liver disease showed significant correlations with liver function parameters. Cirrhosis correlated with low albumin, ascites severity with elevated bilirubin and INR, and splenomegaly with thrombocytopenia. These findings highlight the complementary role of CT imaging and biochemical markers in assessing disease severity and hepatic dysfunction.
References
Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017; 112(1): 18-35. DOI: https://doi.org/10.1038/ajg.2016.517
Vajro P, Maddaluno S, Veropalumbo C. Persistent hypertransaminasemia in asymptomatic children: a stepwise approach. World J Gastroenterol. 2013; 19(18): 2740-2751. DOI: https://doi.org/10.3748/wjg.v19.i18.2740
Saleem U, Aslam N, Siddique R, Iqbal S, Manan M. Hepatitis C virus: Its prevalence, risk factors and genotype distribution in Pakistan. Eur J Inflamm. 2022; 20: 1721727X 221144391. DOI: https://doi.org/10.1177/1721727X221144391
Abdulamir HA, Aldafaay AAA, Al-Shammari AH. The role of liver function tests in monitoring the effect of enzyme replacement therapy in children with Gaucher disease. Res J Pharm Technol. 2022; 15(8): 3490–3496. DOI: https://doi.org/10.52711/0974-360X.2022.00585
R R, Sangameshwar A, Tan YY, Teh Kim Jun K, Tham TY, Cheah Chang Chuen M. Approach to abnormal liver biochemistries in the primary care setting. Cureus. 2024; 16(3): e56541. DOI: https://doi.org/10.7759/cureus.56541
Oh RC, Hustead TR. Causes and evaluation of mildly elevated liver transaminase levels. Am Fam Physician. 2011; 84(9): 1003-1008.
Pandeya A, Shreevastva NK, Dhungana A, Pandeya A. Evaluation of liver enzymes and calculation of AST to ALT ratio in patients with acute viral hepatitis. Europasian J Med Sci. 2021; 3(2): 35–39. DOI: https://doi.org/10.46405/ejms.v3i2.255
Zheng JR, Wang ZL, Jiang SZ, Chen HS, Feng B. Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients. World J Hepatol. 2023; 15(6): 813-825. DOI: https://doi.org/10.4254/wjh.v15.i6.813
Kim DY, Cho KC. Extremely low serum alanine transaminase level is associated with all-cause mortality in the elderly after intracranial hemorrhage. J Korean Neurosurg Soc. 2021; 64(3): 460-468. DOI: https://doi.org/10.3340/jkns.2020.0212
Islam ASM, Muttalib MA, Islam MN, Haque MR, Hoque MR. Study of serum lipid profile and aminotransferases (ALT and AST) in non-obese, non-diabetic nonalcoholic fatty liver disease. J Rangpur Med Col. 2022; 7(2): 35–39. DOI: https://doi.org/10.3329/jrpmc.v7i2.62643
Ray G. Management of liver diseases: Current perspectives. World J Gastroenterol. 2022; 28(40): 5818-5826. DOI: https://doi.org/10.3748/wjg.v28.i40.5818
Tang M, Wu Y, Hu N, Lin C, He J, Xia X, et al. A combination model of CT-based radiomics and clinical biomarkers for staging liver fibrosis in the patients with chronic liver disease. Sci Rep. 2024; 14(1): 20230. DOI: https://doi.org/10.1038/s41598-024-70891-9
Kotoh K, Fukushima M, Horikawa Y, Yamashita S, Kohjima M, Nakamuta M, et al. Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis. Exp Ther Med. 2012; 3(1): 72-75. DOI: https://doi.org/10.3892/etm.2011.370
Wang Y, Zhang J, Li Y, et al. Correlation of imaging-based ascites grading with liver function and prognosis in cirrhotic patients. Abdom Radiol. 2022; 47(10): 3562–3570.
Luca A, Caruso S, Milazzo M, Marrone G, Mamone G, Crinò F, et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology. 2012; 265(1): 124-132. DOI: https://doi.org/10.1148/radiol.12112236
Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005; 54(5): 691-697. DOI: https://doi.org/10.1136/gut.2004.042796
Yeom SK, Lee CH, Cha SH, Park CM. Prediction of liver cirrhosis, using diagnostic imaging tools. World J Hepatol. 2015; 7(17): 2069-2079. DOI: https://doi.org/10.4254/wjh.v7.i17.2069
Peng Y, Qi X, Guo X. Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore). 2016; 95(8): e2877. DOI: https://doi.org/10.1097/MD.0000000000002877
Sharma P. Value of Liver Function Tests in Cirrhosis. J Clin Exp Hepatol. 2022; 12(3): 948-964. DOI: https://doi.org/10.1016/j.jceh.2021.11.004
Berzigotti A, Seijo S, Arena U, Abraldes JG, Vizzutti F, García-Pagán JC, Pinzani M, Bosch J. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterol. 2013; 144(1): 102-111.e1. DOI: https://doi.org/10.1053/j.gastro.2012.10.001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Moeen ud din Khan Khalil, Syed Kazim Shah Bukhari, Syed Murtaza Shah Bukhari, Mian Zia Shah, Mian Raza Shah
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
Non Commercial — You may not use the material for commercial purposes.
-
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a 
